Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation-Reference-Cited by-同舟云学术

Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation

Published:2007-06 Issue:1 Volume:358 Page:241-246
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Ahmed Hafiz,Banerjee Partha P.,Vasta Gerardo R.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference26 articles.

1. Galectins as modulators of tumour progression;Liu;Nat. Rev. Cancer,2005

2. On the role of galectin-3 in cancer apoptosis;Nakahara;Apoptosis,2005

3. Galectinomics: a lesson in complexity;Cooper;Biochim. Biophys. Acta,2002

4. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells;Gong;Cancer Res.,1999

5. Knowledge of epigenetic influence for prostate cancer therapy;Watanabe;Curr. Cancer Drug Targets,2006

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA;The Prostate;2024-06-02

2. Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases;International Journal of Molecular Sciences;2023-05-01

3. Estrogen receptors regulate galectin‑3 in androgen‑independent DU‑145 prostate cancer cells;Oncology Reports;2023-03-20

4. Gal-3 Protein Expression and Localization in Prostate Tumours;Current Oncology;2023-02-23

5. Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?;Molecular Biology Reports;2022-12-30